Haemonetics reported $111.41M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
Globus Medical USD 262.21M 17.63M Sep/2026
Haemonetics USD 111.41M 15.25M Sep/2026
ICU Medical USD 113.91M 3.88M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Neogen USD 41.6M 3.8M Jun/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 148M 18.7M Sep/2026
ResMed USD 533.74M 26.04M Sep/2026
STAAR Surgical USD 14.36M 5.64M Sep/2026
Steris USD 413.1M 29.9M Jun/2026
Stryker USD 1.83B 102M Sep/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 8.62B 108.05B Sep/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
US Physical Therapy USD 27.78M 829K Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026